Dr. Scott Brakenridge Appointed NIH Study Section Chair

The University of Washington Department of Surgery is pleased to announce that Scott C. Brakenridge, MD, FACS, Professor of Surgery in the Division of Trauma, Burn & Critical Care Surgery at Harborview Medical Center, has been appointed Chair of the National Institutes of Health (NIH) Maximizing Investigators’ Research Award (MRAD) Study Section. Dr. Brakenridge will serve as Chair from 2026–2028, following five years as a standing member and ad hoc Chair of the committee.
The appointment recognizes Dr. Brakenridge’s national leadership in biomedical research and scientific peer review. NIH study section chairs oversee the scientific review process for federal research grant applications, ensuring that proposals are evaluated fairly, rigorously, and according to the highest standards of scientific excellence. As Chair, Dr. Brakenridge will lead meetings of nationally recognized scientists and physician-scientists responsible for evaluating investigator-initiated research proposals from institutions across the United States.
The MRAD study section reviews applications submitted through the Maximizing Investigators’ Research Award (MIRA; R35) program, which has become the primary funding mechanism used by National Institute of General Medical Sciences (NIGMS) to support independent investigators. Rather than funding individual projects, the R35 mechanism provides long-term support for an investigator’s overall research program, allowing scientists greater flexibility to pursue innovative, high-impact discoveries.
Dr. Brakenridge’s own research focuses on the immunology of severe traumatic injury and critical illness, with an emphasis on defining immune endotypes that drive chronic critical illness and poor long-term recovery after severe trauma and surgical sepsis. His laboratory integrates advanced immunophenotyping, genomics, and translational clinical research to develop precision medicine approaches for critically ill patients. He currently serves as Principal Investigator of an NIH/NIGMS R35 award investigating immunological endotyping following severe trauma.
The appointment reflects national recognition of Dr. Brakenridge’s scientific leadership and places him among a small group of surgeon-scientists entrusted by the NIH to lead peer review of one of its premier investigator-initiated research programs. Given the relatively small representation of surgeon-scientists within the NIH peer review system, the appointment is a notable distinction recognizing sustained scientific excellence, leadership, and commitment to advancing the nation’s biomedical research enterprise.
